Atlas
Back to RCM
Legal / Service Provider·RCM

Holly Buckley

Partner and Chair of the Healthcare Department at McGuireWoods LLP

Chicago, Illinois, USA

HB
Why they matter

Chairs McGuireWoods' Healthcare Department and co-chairs one of the largest healthcare PE conferences; she structures physician-practice and healthcare-services buyouts and pressure-tests the regulatory risk beneath them.

Background

Holly Buckley is a partner in McGuireWoods' Chicago office and chair of the firm's Healthcare Department. She counsels private equity funds, hospitals and health systems, physician practices, and ambulatory surgery centers on M&A structuring, regulatory due diligence, and compliance, with deep expertise in anti-kickback, Stark law, and HIPAA issues. She co-chairs the firm's Healthcare Private Equity and Finance Conference, one of the largest events in the industry.

Notable deals

  • 2022
    Led McGuireWoods team advising Assured Healthcare Partners on its partnership with Cardiovascular Health Clinic to form Cardiovascular Health Partners, a heart and vascular care platform
  • 2021
    Named a Healthcare and Life Sciences Trailblazer by the National Law Journal for deal work and leadership of the firm's Healthcare Private Equity & Finance Conference
  • 2019
    Named to Mergers & Acquisitions magazine's 'Most Influential Women in Mid-Market M&A' list of 36 honorees nationwide

Call-prep brief

Background

  • Partner in McGuireWoods' Chicago office; chairs the firm's Healthcare Department and co-chairs its Healthcare Private Equity and Finance Conference, one of the largest gatherings of healthcare PE sponsors and lenders in the U.S.
  • Practice sits at the intersection of healthcare M&A and regulation: transaction structuring, regulatory due diligence, affiliation agreements, anti-kickback and Stark law, HIPAA privacy and security.
  • Recognized by Chambers USA, Legal 500, Best Lawyers (2007-2026), NLJ Trailblazer (2021), and Mergers & Acquisitions' Most Influential Women in Mid-Market M&A (2019).

Current focus

  • Advises PE sponsors on physician practice, behavioral health, hospital, and ambulatory surgery center transactions — the provider-side ecosystem where RCM vendors sell.
  • Publishes actively on The Healthcare Investor blog and hosts the 'Across the Table' podcast; visible commentator on PE-in-healthcare trends and regulatory scrutiny of sponsor-backed roll-ups.

What they care about

  • Deal structures that survive regulatory diligence; billing and coding compliance is exactly where RCM diligence lives.
  • Building McGuireWoods' healthcare PE franchise — she values relationships with active, credible sponsors.

Sensitivities

  • She is counsel, not a banker: don't ask her to shop targets or share client-confidential pipeline. Conflicts checks may limit what she can discuss.

Questions to ask

  1. Where is regulatory diligence killing or repricing RCM and billing-adjacent deals right now?
  2. Which RCM capabilities do her provider and sponsor clients most often find missing at diligence?
  3. How is enforcement attention on PE-backed providers changing how sponsors structure RCM carve-outs and MSAs?

Outreach draft

Subject
Healthcare RCM diligence — quick perspective
Hi Holly, We're a private equity team evaluating platforms in revenue cycle management, and your vantage point as chair of McGuireWoods' Healthcare Department — and from the Healthcare Private Equity and Finance Conference — is exactly the perspective we're missing. We'd value 30 minutes on how regulatory diligence is reshaping billing-adjacent deals, and where you see compliance risk concentrating in RCM specifically. Happy to work around your schedule, and to explore whether there's a broader way to work together as we move toward a transaction. Best regards, [Your name]

Linked companies

Sources